BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26454545)

  • 1. Experimental design of a liposomal lipid system: A potential strategy for paclitaxel-based breast cancer treatment.
    Barbosa MV; Monteiro LO; Carneiro G; Malagutti AR; Vilela JM; Andrade MS; Oliveira MC; Carvalho-Junior AD; Leite EA
    Colloids Surf B Biointerfaces; 2015 Dec; 136():553-61. PubMed ID: 26454545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel-Loaded Folate-Coated pH-Sensitive Liposomes Enhance Cellular Uptake and Antitumor Activity.
    Monteiro LOF; Fernandes RS; Castro L; Reis D; Cassali GD; Evangelista F; Loures C; Sabino AP; Cardoso V; Oliveira MC; Branco de Barros A; Leite EA
    Mol Pharm; 2019 Aug; 16(8):3477-3488. PubMed ID: 31257891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel-loaded folate-coated long circulating and pH-sensitive liposomes as a potential drug delivery system: A biodistribution study.
    Monteiro LOF; Fernandes RS; Oda CMR; Lopes SC; Townsend DM; Cardoso VN; Oliveira MC; Leite EA; Rubello D; de Barros ALB
    Biomed Pharmacother; 2018 Jan; 97():489-495. PubMed ID: 29091899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-circulating and fusogenic liposomes loaded with a glucoevatromonoside derivative induce potent antitumor response.
    Gomes ER; Novais MVM; Silva IT; Barros ALB; Leite EA; Munkert J; Frade ACM; Cassali GD; Braga FC; Pádua RM; Oliveira MC
    Biomed Pharmacother; 2018 Dec; 108():1152-1161. PubMed ID: 30372816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomes co-encapsulating doxorubicin and glucoevatromonoside derivative induce synergic cytotoxic response against breast cancer cell lines.
    Novais MVM; Gomes ER; Miranda MC; Silva JO; Gomes DA; Braga FC; Pádua RM; Oliveira MC
    Biomed Pharmacother; 2021 Apr; 136():111123. PubMed ID: 33486211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy.
    Eloy JO; Petrilli R; Chesca DL; Saggioro FP; Lee RJ; Marchetti JM
    Eur J Pharm Biopharm; 2017 Jun; 115():159-167. PubMed ID: 28257810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR Targeted Paclitaxel and Piperine Co-loaded Liposomes for the Treatment of Triple Negative Breast Cancer.
    Burande AS; Viswanadh MK; Jha A; Mehata AK; Shaik A; Agrawal N; Poddar S; Mahto SK; Muthu MS
    AAPS PharmSciTech; 2020 May; 21(5):151. PubMed ID: 32440910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of acute toxicity and in vitro antitumor activity of a novel doxorubicin-loaded folate-coated pH-sensitive liposome.
    de Oliveira Silva J; Fernandes RS; de Alcântara Lemos J; Cassali GD; de Paula Sabino A; Townsend DM; Oliveira MC; de Barros ALB
    Biomed Pharmacother; 2023 Sep; 165():115280. PubMed ID: 37541172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folate-coated, long-circulating and pH-sensitive liposomes enhance doxorubicin antitumor effect in a breast cancer animal model.
    de Oliveira Silva J; Fernandes RS; Ramos Oda CM; Ferreira TH; Machado Botelho AF; Martins Melo M; de Miranda MC; Assis Gomes D; Dantas Cassali G; Townsend DM; Rubello D; Oliveira MC; de Barros ALB
    Biomed Pharmacother; 2019 Oct; 118():109323. PubMed ID: 31400669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation.
    Ravar F; Saadat E; Gholami M; Dehghankelishadi P; Mahdavi M; Azami S; Dorkoosh FA
    J Control Release; 2016 May; 229():10-22. PubMed ID: 26968799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Antitumor Activity of Long-Circulating and pH-Sensitive Liposomes Containing Ursolic Acid in Animal Models of Breast Tumor and Gliosarcoma.
    Rocha TG; Lopes SC; Cassali GD; Ferreira Ê; Veloso ES; Leite EA; Braga FC; Ferreira LA; Balvay D; Garofalakis A; Oliveira MC; Tavitian B
    Integr Cancer Ther; 2016 Dec; 15(4):512-524. PubMed ID: 27130721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Tumor Penetration of Paclitaxel Loaded pH Sensitive Cleavable Liposomes by Depletion of Tumor Collagen I in Breast Cancer.
    Zhang L; Wang Y; Yang Y; Liu Y; Ruan S; Zhang Q; Tai X; Chen J; Xia T; Qiu Y; Gao H; He Q
    ACS Appl Mater Interfaces; 2015 May; 7(18):9691-701. PubMed ID: 25845545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel-Loaded pH-Sensitive Liposome: New Insights on Structural and Physicochemical Characterization.
    Monteiro LOF; Malachias Â; Pound-Lana G; Magalhães-Paniago R; Mosqueira VCF; Oliveira MC; de Barros ALB; Leite EA
    Langmuir; 2018 May; 34(20):5728-5737. PubMed ID: 29676924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-delivery of paclitaxel and anti-survivin siRNA via redox-sensitive oligopeptide liposomes for the synergistic treatment of breast cancer and metastasis.
    Chen X; Zhang Y; Tang C; Tian C; Sun Q; Su Z; Xue L; Yin Y; Ju C; Zhang C
    Int J Pharm; 2017 Aug; 529(1-2):102-115. PubMed ID: 28642204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.
    Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q
    Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor activity of folate targeted biodegradable polymer-paclitaxel conjugate micelles on EMT-6 breast cancer model.
    Wu D; Zheng Y; Hu X; Fan Z; Jing X
    Mater Sci Eng C Mater Biol Appl; 2015 Aug; 53():68-75. PubMed ID: 26042692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomes Containing Gadodiamide: Preparation, Physicochemical Characterization, and In Vitro Cytotoxic Evaluation.
    Maia ALC; Fernandes C; de Oliveira CNP; Teixeira CS; Oliveira MS; Soares DCF; Ramaldes GA
    Curr Drug Deliv; 2017; 14(4):566-574. PubMed ID: 27605018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomes with high encapsulation capacity for paclitaxel: Preparation, characterisation and in vivo anticancer effect.
    Koudelka S; Turánek-Knötigová P; Masek J; Korvasová Z; Skrabalová M; Plocková J; Bartheldyová E; Turánek J
    J Pharm Sci; 2010 May; 99(5):2309-19. PubMed ID: 19904827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Long-Circulating and Fusogenic Liposomes Co-encapsulating Paclitaxel and Doxorubicin in Synergistic Ratio for the Treatment of Breast Cancer.
    Roque MC; Franco MS; Vilela JMC; Andrade MS; de Barros ALB; Leite EA; Oliveira MC
    Curr Drug Deliv; 2019; 16(9):829-838. PubMed ID: 31622204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Layer-by-layer assembly of chitosan stabilized multilayered liposomes for paclitaxel delivery.
    Chen MX; Li BK; Yin DK; Liang J; Li SS; Peng DY
    Carbohydr Polym; 2014 Oct; 111():298-304. PubMed ID: 25037355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.